BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

239 related articles for article (PubMed ID: 12815101)

  • 1. Elucidation of the molecular logic by which misfolded alpha 1-antitrypsin is preferentially selected for degradation.
    Wu Y; Swulius MT; Moremen KW; Sifers RN
    Proc Natl Acad Sci U S A; 2003 Jul; 100(14):8229-34. PubMed ID: 12815101
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Oligosaccharide modification in the early secretory pathway directs the selection of a misfolded glycoprotein for degradation by the proteasome.
    Liu Y; Choudhury P; Cabral CM; Sifers RN
    J Biol Chem; 1999 Feb; 274(9):5861-7. PubMed ID: 10026209
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Processing by endoplasmic reticulum mannosidases partitions a secretion-impaired glycoprotein into distinct disposal pathways.
    Cabral CM; Choudhury P; Liu Y; Sifers RN
    J Biol Chem; 2000 Aug; 275(32):25015-22. PubMed ID: 10827201
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Human endoplasmic reticulum mannosidase I is subject to regulated proteolysis.
    Wu Y; Termine DJ; Swulius MT; Moremen KW; Sifers RN
    J Biol Chem; 2007 Feb; 282(7):4841-4849. PubMed ID: 17166854
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Enhancement of endoplasmic reticulum (ER) degradation of misfolded Null Hong Kong alpha1-antitrypsin by human ER mannosidase I.
    Hosokawa N; Tremblay LO; You Z; Herscovics A; Wada I; Nagata K
    J Biol Chem; 2003 Jul; 278(28):26287-94. PubMed ID: 12736254
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The cytoplasmic tail of human mannosidase Man1b1 contributes to catalysis-independent quality control of misfolded alpha1-antitrypsin.
    Sun AH; Collette JR; Sifers RN
    Proc Natl Acad Sci U S A; 2020 Oct; 117(40):24825-24836. PubMed ID: 32958677
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A novel ER alpha-mannosidase-like protein accelerates ER-associated degradation.
    Hosokawa N; Wada I; Hasegawa K; Yorihuzi T; Tremblay LO; Herscovics A; Nagata K
    EMBO Rep; 2001 May; 2(5):415-22. PubMed ID: 11375934
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Organizational diversity among distinct glycoprotein endoplasmic reticulum-associated degradation programs.
    Cabral CM; Liu Y; Moremen KW; Sifers RN
    Mol Biol Cell; 2002 Aug; 13(8):2639-50. PubMed ID: 12181335
    [TBL] [Abstract][Full Text] [Related]  

  • 9. EDEM as an acceptor of terminally misfolded glycoproteins released from calnexin.
    Oda Y; Hosokawa N; Wada I; Nagata K
    Science; 2003 Feb; 299(5611):1394-7. PubMed ID: 12610305
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Human OS-9, a lectin required for glycoprotein endoplasmic reticulum-associated degradation, recognizes mannose-trimmed N-glycans.
    Hosokawa N; Kamiya Y; Kamiya D; Kato K; Nagata K
    J Biol Chem; 2009 Jun; 284(25):17061-17068. PubMed ID: 19346256
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The proteasome participates in degradation of mutant alpha 1-antitrypsin Z in the endoplasmic reticulum of hepatoma-derived hepatocytes.
    Teckman JH; Burrows J; Hidvegi T; Schmidt B; Hale PD; Perlmutter DH
    J Biol Chem; 2001 Nov; 276(48):44865-72. PubMed ID: 11577074
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vitro mannose trimming property of human ER α-1,2 mannosidase I.
    Aikawa J; Matsuo I; Ito Y
    Glycoconj J; 2012 Jan; 29(1):35-45. PubMed ID: 22160784
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Yeast N-glycanase distinguishes between native and non-native glycoproteins.
    Hirsch C; Misaghi S; Blom D; Pacold ME; Ploegh HL
    EMBO Rep; 2004 Feb; 5(2):201-6. PubMed ID: 14726951
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Stimulation of ERAD of misfolded null Hong Kong alpha1-antitrypsin by Golgi alpha1,2-mannosidases.
    Hosokawa N; You Z; Tremblay LO; Nagata K; Herscovics A
    Biochem Biophys Res Commun; 2007 Oct; 362(3):626-32. PubMed ID: 17727818
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Golgi localization of ERManI defines spatial separation of the mammalian glycoprotein quality control system.
    Pan S; Wang S; Utama B; Huang L; Blok N; Estes MK; Moremen KW; Sifers RN
    Mol Biol Cell; 2011 Aug; 22(16):2810-22. PubMed ID: 21697506
    [TBL] [Abstract][Full Text] [Related]  

  • 16. N-glycan structure of a short-lived variant of ribophorin I expressed in the MadIA214 glycosylation-defective cell line reveals the role of a mannosidase that is not ER mannosidase I in the process of glycoprotein degradation.
    Ermonval M; Kitzmüller C; Mir AM; Cacan R; Ivessa NE
    Glycobiology; 2001 Jul; 11(7):565-76. PubMed ID: 11447136
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Htm1 protein generates the N-glycan signal for glycoprotein degradation in the endoplasmic reticulum.
    Clerc S; Hirsch C; Oggier DM; Deprez P; Jakob C; Sommer T; Aebi M
    J Cell Biol; 2009 Jan; 184(1):159-72. PubMed ID: 19124653
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Endoplasmic reticulum lectin XTP3-B inhibits endoplasmic reticulum-associated degradation of a misfolded α1-antitrypsin variant.
    Fujimori T; Kamiya Y; Nagata K; Kato K; Hosokawa N
    FEBS J; 2013 Mar; 280(6):1563-75. PubMed ID: 23356641
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The mammalian UPR boosts glycoprotein ERAD by suppressing the proteolytic downregulation of ER mannosidase I.
    Termine DJ; Moremen KW; Sifers RN
    J Cell Sci; 2009 Apr; 122(Pt 7):976-84. PubMed ID: 19258393
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Endomannosidase processes oligosaccharides of alpha1-antitrypsin and its naturally occurring genetic variants in the Golgi apparatus.
    Torossi T; Fan JY; Sauter-Etter K; Roth J; Ziak M
    Cell Mol Life Sci; 2006 Aug; 63(16):1923-32. PubMed ID: 16871372
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.